VISTIN PHARMA AS

0661 OSLO

Finances

Share Ownership

Return on Equity

−5,29 %

Current Ratio

0,57

Debt-to-Equity Ratio

1,31

Key figures (NOK)	2022	2021	2020	2019
Revenue	304 852 000	278 623 000	253 906 000	228 129 000
Net Income	−2 864 000	27 654 000	29 372 000	14 720 000
Total Assets	404 516 000	317 792 000	224 458 000	201 681 000
Total Equity	54 178 000	54 831 000	28 335 000	33 697 000

Income (NOK)	2022	2021	2020	2019
Revenue	304 852 000	278 623 000	253 906 000	228 129 000
Expenditure	306 754 000	240 676 000	205 339 000	206 601 000
Operating Profit	−1 902 000	37 947 000	48 567 000	21 528 000
Financial Income	9 546 000	5 001 000	12 322 000	4 391 000
Financial Costs	11 279 000	7 674 000	23 204 000	7 022 000
Financial Balance	−1 733 000	−2 673 000	−10 882 000	−2 631 000
Earnings Before Tax	−3 635 000	35 274 000	37 685 000	18 897 000
Tax	−771 000	7 620 000	8 313 000	4 177 000
Net Income	−2 864 000	27 654 000	29 372 000	14 720 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	246 769 000	194 709 000	145 261 000	102 318 000
Total Current Assets	157 747 000	123 083 000	79 197 000	99 363 000
Total Assets	404 516 000	317 792 000	224 458 000	201 681 000
Total Retained Equity	0	0	0	0
Total Equity	54 178 000	54 831 000	28 335 000	33 697 000
Total Long-Term Debt	71 223 000	73 856 000	114 880 000	114 334 000
Total Current Debt	279 114 000	189 103 000	81 244 000	53 650 000
Total Equity and Debt	404 515 000	317 790 000	224 459 000	201 681 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	287 675 000	275 812 000	253 159 000	227 186 000
Other Income	17 177 000	2 811 000	747 000	943 000
Revenue	304 852 000	278 623 000	253 906 000	228 129 000
Cost of Goods Sold	138 064 000	96 097 000	73 288 000	84 114 000
Salary Costs	77 010 000	71 479 000	70 898 000	67 416 000
Depreciation	12 280 000	10 609 000	9 623 000	8 956 000
Impairment	0	0	0	0
Expenditure	306 754 000	240 676 000	205 339 000	206 601 000
Operating Profit	−1 902 000	37 947 000	48 567 000	21 528 000
Financial Income	9 546 000	5 001 000	12 322 000	4 391 000
Financial Costs	11 279 000	7 674 000	23 204 000	7 022 000
Financial Balance	−1 733 000	−2 673 000	−10 882 000	−2 631 000
Dividends	0	0	0	0
Net Income	−2 864 000	27 654 000	29 372 000	14 720 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	27 338 000	27 289 000	0	516 000
Real Eastate	42 847 000	103 269 000	77 132 000	41 247 000
Machinery and Plant Facilities	175 477 000	59 295 000	62 366 000	53 223 000
Fixtures	1 107 000	4 856 000	5 763 000	7 332 000
Total Tangible Assets	219 431 000	167 420 000	145 261 000	101 802 000
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	246 769 000	194 709 000	145 261 000	102 318 000
Stock	83 446 000	42 907 000	31 788 000	24 107 000
Total Investments	0	0	0	0
Cash, Bank	47 000	13 225 000	9 236 000	25 732 000
Total Current Assets	157 747 000	123 083 000	79 197 000	99 363 000
Total Assets	404 516 000	317 792 000	224 458 000	201 681 000
Total Equity	54 178 000	54 831 000	28 335 000	33 697 000
Short-Term Group Debt	159 537 000	147 666 000	43 458 000	12 289 000
Total Long-Term Debt	71 223 000	73 856 000	114 880 000	114 334 000
Creditors	25 865 000	10 030 000	13 538 000	15 715 000
Unpaid Taxes	5 721 000	1 737 000	2 604 000	3 591 000
Dividends	0	0	0	0
Other Current Debt	87 991 000	29 508 000	21 644 000	18 259 000
Total Current Debt	279 114 000	189 103 000	81 244 000	53 650 000
Total Equity and Debt	404 515 000	317 790 000	224 459 000	201 681 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−5,29 %	50,43 %	103,66 %	43,68 %
Debt-to-Equity Ratio	1,31	1,35	4,05	3,39
Operating Profit Margin	−0,62 %	13,62 %	19,13 %	9,44 %
Current Ratio	0,57	0,65	0,97	1,85
Quick Ratio	0,81	0,84	1,6	3,36
Equity Ratio	0,13	0,17	0,13	0,17
Gross Profit Margin	54,71 %	65,51 %	71,14 %	63,13 %